Found: 9
Select item for more details and to access through your institution.
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2073, doi. 10.1093/cid/ciz653
- By:
- Publication type:
- Article
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00943
- By:
- Publication type:
- Article
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1732, doi. 10.1093/cid/ciae010
- By:
- Publication type:
- Article
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 1, p. 202, doi. 10.1093/cid/ciad471
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 6, p. 761, doi. 10.1093/infdis/jiac327
- By:
- Publication type:
- Article
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
- Published in:
- Journal of Infectious Diseases, 2018, v. 217, n. 10, p. 1616, doi. 10.1093/infdis/jiy065
- By:
- Publication type:
- Article
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
- Published in:
- 2017
- By:
- Publication type:
- journal article